LUMATE-AT 60 Inj.
MRP: 220
Packaging: 60mg
Pack Type: injection
Composition:
Artesunate 60mg
Indication:
Provides quick control on the symptoms of Malaria Packing: 60mg
Description:
Artesunate 60mg is a fast-acting antimalarial injection used for the treatment of severe malaria, especially Plasmodium falciparum infections, including drug-resistant strains. Artesunate is a semi-synthetic derivative of artemisinin, derived from the sweet wormwood plant (Artemisia annua), and works by rapidly reducing the parasite load in the bloodstream.
It is administered intravenously or intramuscularly in hospital settings under medical supervision, especially for critically ill patients or those unable to take oral medications.
Tags:
- Rapid action against Plasmodium falciparum
- Effective in multi-drug resistant malaria
- Reduces parasite count within hours
- Essential for patients unable to take oral drugs
- Recommended by WHO for severe malaria
Usage Information
Dosage
Adults & Children: Initial dose: 2.4 mg/kg IV or IM at 0, 12, and 24 hours, then once daily Route: Intravenous (IV) or Intramuscular (IM) injection Treatment duration: 3–7 days, followed by complete oral ACT (e.g., Artemether + Lumefantrine) Note: Reconstitution with sodium bicarbonate + normal saline required before administration
Side Effects
Temporary reduction in red blood cells (hemolysis) Dizziness or headache Nausea or vomiting Fever or chills (may be due to malaria itself) Injection site pain or swelling Rare: Neutropenia, liver enzyme elevation
Contraindications
Known hypersensitivity to artemisinin derivatives Use with caution in patients with severe liver or kidney disease Not recommended for prevention or prophylaxis Caution in patients with G6PD deficiency (due to risk of hemolysis)